Cancer Risk Assessment in Individuals with Hidradenitis Suppurativa: A Comprehensive Review and Meta-Analysis - Takeaways - MDSpire

Cancer Risk Assessment in Individuals with Hidradenitis Suppurativa: A Comprehensive Review and Meta-Analysis

  • By

  • Daniel Isufi

  • Mikkel Bak Jensen

  • Nikolai Loft

  • Rune Kjærsgaard Andersen

  • March 11, 2026

  • 0 min

Share

  • 1

    Hidradenitis suppurativa (HS) is linked to a significantly elevated overall cancer risk, including gastrointestinal and hematological cancers.

  • 2

    The meta-analysis included 11 studies with over 600,000 HS patients and approximately 400 million controls.

  • 3

    Patients with HS showed increased risks for Hodgkin and non-Hodgkin lymphoma, as well as respiratory and head and neck cancers.

  • 4

    Confounding factors like smoking, BMI, and alcohol intake need to be adjusted in future studies to clarify cancer risk.

  • 5

    The findings highlight the importance of understanding long-term cancer risks associated with chronic inflammatory conditions like HS.

Original Source(s)

Cancer Risk Assessment in Individuals with Hidradenitis Suppurativa: A Comprehensive Review and Meta-Analysis

  • by Daniel Isufi, Mikkel Bak Jensen, Nikolai Loft, Rune Kjærsgaard Andersen

  • March 11, 2026

Related Content

NLRP3 inflammasomes at the ARDS-cancer interface: mechanisms and translational hypotheses

The Role of Inflammatory Biomarkers in Disease Severity and Treatment Response across Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa—A Narrative Review

High-frequency ultrasound combined with superb microvascular imaging for differential diagnosis of basal cell carcinoma and seborrheic keratosis: a retrospective analysis with nomogram implementation